Listed

Fresenius Medical Care AG: Form 20-F for the period ended Dec 31, 2023

Filed with the SEC on Feb 20, 2024 and accepted by EDGAR at Feb 20, 2024, 10:02 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2023-01-01 to 2023-12-31EUR 19.45bnifrs-full:Revenue
Cost of revenue12 months2023-01-01 to 2023-12-31EUR 14.53bnifrs-full:CostOfSales
Operating income12 months2023-01-01 to 2023-12-31EUR 1.37bnifrs-full:ProfitLossFromOperatingActivities
Income tax12 months2023-01-01 to 2023-12-31EUR 300.6mifrs-full:IncomeTaxExpenseContinuingOperations
Net income12 months2023-01-01 to 2023-12-31EUR 499.0mifrs-full:ProfitLossAttributableToOwnersOfParent
Diluted EPS12 months2023-01-01 to 2023-12-31EUR 1.70ifrs-full:DilutedEarningsLossPerShare
Basic EPS12 months2023-01-01 to 2023-12-31EUR 1.70ifrs-full:BasicEarningsLossPerShare
Operating cash flow12 months2023-01-01 to 2023-12-31EUR 2.63bnifrs-full:CashFlowsFromUsedInOperatingActivities
Cash and equivalentsAt period end2023-12-31EUR 1.40bnifrs-full:CashAndCashEquivalents
Current assetsAt period end2023-12-31EUR 8.70bnifrs-full:CurrentAssets
Total assetsAt period end2023-12-31EUR 33.93bnifrs-full:Assets
Current liabilitiesAt period end2023-12-31EUR 6.11bnifrs-full:CurrentLiabilities
Total liabilitiesAt period end2023-12-31EUR 19.10bnifrs-full:Liabilities
Shareholders' equityAt period end2023-12-31EUR 13.62bnifrs-full:EquityAttributableToOwnersOfParent
Shares outstandingAt period end2023-12-31293,413,449 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001104659-24-025293. Last ingested by Listed: Nov 3, 2026, 10:24 ET. Listed shows no prices and gives no investment advice.